Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.62	31.74	31.74	43.65	10.19	30.87
Cash & Short-Term Investments	27.62	31.74	31.74	43.65	10.19	30.87
Cash Growth	-5.75%	-0.00%	-27.29%	328.30%	-66.98%	-26.35%
Accounts Receivable	13.61	16.78	15.48	14.02	10.6	13.04
Other Receivables	-	-	-	-	7.64	8.13
Total Trade Receivables	13.61	16.78	15.48	14.02	18.25	21.16
Inventory	10.75	8.6	7.56	9.92	11.8	6.78
Other Current Assets	1.18	1.35	1.66	2.76	2.74	1.93
Total Current Assets	53.16	58.47	56.44	70.36	42.97	60.74
Net Property, Plant & Equipment	6.14	6.62	6.74	7.15	7.59	6.87
Other Long-Term Assets	1.78	1.75	1.66	1.73	1.22	1.11
Total Assets	61.07	66.84	64.84	79.24	51.78	68.72
Accounts Payable	2.19	3.06	2.62	2.71	2.67	2.63
Accrued Expenses	6.69	8.21	7.75	9.66	8.93	10.29
Current Portion of Leases	0.47	0.43	0.36	0.37	0.25	0.29
Total Current Liabilities	9.35	11.7	10.72	12.74	11.85	13.21
Long-Term Debt	35.33	34.85	33.89	33.19	-	-
Long-Term Leases	3.83	4.06	4.52	4.95	0.54	0.02
Other Long-Term Liabilities	1.47	1.4	1.38	1.44	1.59	1.49
Total Long-Term Liabilities	40.63	40.31	39.79	39.58	2.13	1.51
Total Liabilities	49.98	52.01	50.51	52.32	13.98	14.71
Common Stock	0.04	0.04	0.04	0.04	0.04	0.03
Additional Paid-in Capital	105.09	103.62	92.08	81.11	73.28	66.22
Retained Earnings	-94.47	-89.12	-77.91	-54.45	-35.74	-12.55
Total Common Shareholders' Equity	10.66	14.54	14.21	26.7	37.58	53.7
Minority Interest	0.43	0.29	0.13	0.22	0.21	0.31
Shareholders' Equity	11.09	14.83	14.34	26.92	37.79	54.01
Total Liabilities & Equity	61.07	66.84	64.84	79.24	51.78	68.72
Total Debt	39.63	39.34	38.76	38.5	0.8	0.31
Net Cash (Debt)	-12.01	-7.6	-7.02	5.15	9.4	30.57
Net Cash Growth	-	-	-	-45.18%	-69.26%	-25.88%
Net Cash Per Share	-0.28	-0.18	-0.20	0.15	0.27	0.89
Book Value	10.66	14.54	14.21	26.7	37.58	53.7
Book Value Per Share	0.25	0.35	0.40	0.77	1.09	1.56
Tangible Book Value	10.66	14.54	14.21	26.7	37.58	53.7
Tangible Book Value Per Share	0.25	0.35	0.40	0.77	1.09	1.56

SEC Filings: 10-K · 10-Q